CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells. (6th November 2014) - Morishima, Chihiro; McNeel, Douglas G; Patel, Manish R; Kohrt, Holbrook; Waldmann, Thomas A; Thompson, John A; Conlon, Kevin; M Sondel, Paul; Wakelee, Heather; Disis, Mary L; Creekmore, Stephen P; Miller, Jeffrey S